Risk Factors and Treatment Outcome Analysis Associated with Second-Line Drug-Resistant Tuberculosis
The present study aimed at analyzing the treatment outcomes and risk factors associated with fluoroquinolone drug resistance having mutations in the <i>gyrA</i> and <i>gyrB</i> genes. A total of 258 pulmonary tuberculosis samples with first-line drug-resistant (H, R, or HR) w...
Saved in:
Main Authors: | Muralidhar Aaina (Author), Kaliyaperumal Venkatesh (Author), Brammacharry Usharani (Author), Muthukumar Anbazhagi (Author), Gerard Rakesh (Author), Muthaiah Muthuraj (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prevalence of rifampicin-resistant Mycobacterium tuberculosis among human-immunodeficiency-virus-seropositive patients and their treatment outcomes
by: C.K. Vidyaraj, et al.
Published: (2019) -
Second-line Drug Resistance Characterization in Mycobacterium tuberculosis by Genotype MTBDRsl Assay
by: Sunil Sethi, et al.
Published: (2020) -
Genetic Characterization of Second-Line Drug-Resistant and Extensively Drug-Resistant Mycobacterium tuberculosis from the Northern Region of India
by: Rakesh Yadav, et al.
Published: (2018) -
First and Second-Line Anti-Tuberculosis Drug-Resistance Patterns in Pulmonary Tuberculosis Patients in Zambia
by: Ngula Monde, et al.
Published: (2023) -
Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011
by: Hoa Binh Nguyen, et al.
Published: (2016)